Accéder au contenu
Merck

Beneficial effects of Renin-Angiotensin system blockers on testicular steroidogenesis.

The Journal of urology (2014-06-01)
Jorge Luiz Alves-Pereira, Eliete Dalla Corte Frantz, Cristiane da Fonte Ramos
RÉSUMÉ

We evaluated whether antihypertensive drugs that act through the renin-angiotensin system would affect testis function. Ten mice were fed standard chow and 40 received a high energy density diet. At 8 weeks the high energy density diet mice were divided into 4 groups of 10 each. The untreated group received the high energy density diet alone. The 3 treated groups received that diet plus aliskiren (50 mg/kg daily), enalapril (30 mg/kg daily) and losartan (10 mg/kg daily), respectively, for the next 6 weeks. Blood pressure was measured twice monthly. At the end of the treatment period all mice were sacrificed. One-way ANOVA and the Holm-Sidak post hoc test were used to analyze results. The high energy density diet led to a significant increase in blood pressure (p <0.05). All treatments resulted in normalized blood pressure. In regard to reproductive function, and serum testosterone and estradiol the gene and protein expression of StAR, aromatase and luteinizing hormone receptor, and the protein expression of angiotensin-converting enzyme, renin and angiotensin type 1 receptor blocker were significantly decreased by the high energy density diet. Of the treatments only enalapril reverted the changes. Also, angiotensin-converting enzyme, angiotensin type 1 receptor blocker and renin protein expression were lower in all high energy density diet groups except the group that received enalapril. Only angiotensin-converting enzyme inhibitor reverted the hormonal and testis alterations caused by the high energy density diet. This suggests that enalapril should be the drug of choice for a patient who presents with previous reproductive dysfunction.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Enalapril maleate salt, powder, ≥98% (TLC)
Supelco
Enalapril Maleate, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Enalapril maleate, United States Pharmacopeia (USP) Reference Standard
Enalapril maleate, European Pharmacopoeia (EP) Reference Standard
Enalapril for system suitability, European Pharmacopoeia (EP) Reference Standard